Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sayeed Haque

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Neuroscience Letters|June 15, 2004
Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's diseaseYong Zhang, Angela Hayes, Antonia Pritchard, et al.
BMC Cardiovascular Disorders|March 26, 2013
Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trialClaire O'Brien, Emma P Bray, Stirling Bryan, et al.
JAMA|August 27, 2014
Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trialRichard J McManus, Jonathan Mant, M Sayeed Haque, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Neuroscience Letters|June 15, 2004
Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's diseaseYong Zhang, Angela Hayes, Antonia Pritchard, et al.
BMC Cardiovascular Disorders|March 26, 2013
Targets and self-management for the control of blood pressure in stroke and at risk groups (TASMIN-SR): protocol for a randomised controlled trialClaire O'Brien, Emma P Bray, Stirling Bryan, et al.
JAMA|August 27, 2014
Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trialRichard J McManus, Jonathan Mant, M Sayeed Haque, et al.
Pageof 4